Asensus Surgical to Host Investor Day on February 21, 2023
RESEARCH TRIANGLE PARK, N.C., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-01-30, 19:01
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-01-30, 18:32
Daseke Names Adrianne D. Griffin Vice President, Investor
Newly created role with a dedicated proven leader facilitates enhanced communication of the Company’s shareholder value proposition...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-01-28, 05:22
Nogin Announces Jonathan Huberman as Chairman and Chief
TUSTIN, Calif., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Nogin (“Nogin” or the “Company”), a leading provider of innovative Commerce-as-a-Service (CaaS)...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-01-27, 21:06
Duolingo to Announce Fourth Quarter and Full Year 2022
PITTSBURGH, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Duolingo, Inc. (Nasdaq: DUOL), the world's leading mobile learning platform, will announce its results for...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-01-27, 20:43
Fresh Tracks Therapeutics Appoints Andrew Sklawer as Chief
Rob Brown to continue serving as a member of the Board of Directors and as a special advisor to the Company...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-01-27, 20:39
Salarius Pharmaceuticals Presents SP-3164 Preclinical Data
Preclinical data show synergistic activity for the targeted protein degrader SP-3164 with rituximab in non-Hodgkin’s lymphomas, and significantly better...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-01-26, 01:36
